Daiwa Securities Group Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 248 filers reported holding NEKTAR THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2023$05390.0%0.00%
Q2 2023$05390.0%0.00%
Q1 2023$0
-100.0%
5390.0%0.00%
Q4 2022$1
-100.0%
5390.0%0.00%
Q3 2022$2,0000.0%5390.0%0.00%
Q2 2022$2,000
-33.3%
5390.0%0.00%
Q1 2022$3,000
-57.1%
5390.0%0.00%
Q4 2021$7,000
-36.4%
539
-14.4%
0.00%
Q3 2021$11,000
+83.3%
630
+74.5%
0.00%
Q2 2021$6,000
-14.3%
3610.0%0.00%
Q1 2021$7,000
+16.7%
361
+7.1%
0.00%
Q4 2020$6,000
-62.5%
337
-66.1%
0.00%
Q3 2020$16,000
-11.1%
9930.0%0.00%
Q2 2020$18,0000.0%9930.0%0.00%
Q1 2020$18,000
-14.3%
9930.0%0.00%
Q4 2019$21,000
-85.2%
993
-87.3%
0.00%
-100.0%
Q3 2019$142,000
-45.2%
7,820
+7.6%
0.00%
-50.0%
Q2 2019$259,000
+5.7%
7,270
-0.3%
0.00%0.0%
Q1 2019$245,000
+2.1%
7,2940.0%0.00%0.0%
Q4 2018$240,000
-44.1%
7,294
+3.5%
0.00%
-50.0%
Q3 2018$429,000
+34.1%
7,044
+7.6%
0.00%
+33.3%
Q2 2018$320,000
+188.3%
6,544
+527.4%
0.00%
+200.0%
Q1 2018$111,0001,0430.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q4 2020
NameSharesValueWeighting ↓
Camber Capital Management LP 3,500,000$60,060,0002.02%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,772,0001.42%
Rhenman & Partners Asset Management AB 950,000$16,302,0001.11%
MAVERICK CAPITAL LTD 5,761,073$98,860,0000.93%
Birchview Capital, LP 72,000$1,236,0000.74%
Bellevue Group AG 4,101,404$70,380,0000.69%
CM Management, LLC 50,000$858,0000.62%
Duquesne Family Office 1,000,000$17,160,0000.42%
OSTERWEIS CAPITAL MANAGEMENT INC 373,368$6,407,0000.33%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 67,000$1,149,0000.30%
View complete list of NEKTAR THERAPEUTICS shareholders